Healthcare >> Analyst Interviews >> October 5, 2000
ROSS TAYLOR is a Director and Equity Analyst at UBS Warburg LLC, working
in the biotechnology and healthcare services sectors. Prior to joining
the firm, he was a Senior Analyst with Salomon Smith Barney in
Healthcare Services Equity Research for three years and prior to that he
was an assistant Vice President in Equity Research with C.J.
Lawrence/Deutsche Bank Securities. Mr. Taylor was also an Associate
Analyst with Whitehurst & Associates, an economic consulting firm. He
received his AB from Duke University and his MBA from Columbia
University. Profile
TWST: In general, what is the investment approach you use with thebiotechnology industry today?
Mr. Taylor: We suggest investors focus on companies that have good
product stories, strong